[Iridium-192-short-term contact irradiation of malignant tumors in the throat, nose, and ear region].
D006801:Humans; D007495:Iridium / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000532:radiotherapy*; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000627:therapeutic use*; D011878:Radiotherapy / Q000295:instrumentation*
D011868:Radioisotopes; D007495:Iridium
Die Iridium-192-Kurzzeit-Kontaktbestrahlung maligner Tumoren des Hals-Nasen-Ohren-Bereiches.